ARCHIVES

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 32 No. 15 | April 21, 2006

Download PDF Visit The Full Archive

Related Articles

Surgery Without Radiation Found Inadequate for DCIS

December 26, 2003

ASSIST Smoking Intervention gets Under Way In 1991

December 1, 1989

NSAIDs Cut Oral Cancer Risk But Raise Smokers’ Heart Risk

October 28, 2005

Sanding Study Section For Cancer Control Grants Needed, Board Says

May 17, 1985

Study Supports Hypothesis On Mastectomy Timing

June 7, 1991

Daily Vitamin E Supplements Can Lead to Increased PCa Risk

October 28, 2011